While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Despite constraints exerted by GLP-1RAs on bariatric surgery volumes, shares in Intuitive Surgical surged following a ...

In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

This cross-sectional study showed websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially ...

The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.